Mounjaro vs Zepbound: What's Actually Different?

Yes — Mounjaro and Zepbound are the same drug. Both contain tirzepatide, a once-weekly injectable made by Eli Lilly. Tirzepatide is a dual agonist, meaning it activates two gut hormone receptors: GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1). This dual action is what sets it apart from older single-hormone drugs like semaglutide.

So why two names? The U.S. system approves medications for a specific indication (the condition it treats). Lilly brought tirzepatide to market first as Mounjaro in 2022 for type 2 diabetes, then again as Zepbound in late 2023 for chronic weight management. Same molecule, same factory, same syringe — different box and different FDA label. In 2024, Zepbound also gained approval for moderate-to-severe obstructive sleep apnea in adults with obesity, based on the SURMOUNT-OSA trial.

The doses are identical too: both come in single-dose pens at 2.5, 5, 7.5, 10, 12.5, and 15 mg. If you understand how one works, you understand the other. The choice between them is almost never about the medicine itself — it is about what your prescription is for and what your insurance will pay. If you are weighing tirzepatide against the other major option, our guide to [tirzepatide vs semaglutide](/blog/tirzepatide-vs-semaglutide-which-works-better-2026) breaks down the head-to-head data.

The label matters because it decides how your prescription is written, how insurance treats it, and sometimes whether you can get it at all. Even though Mounjaro and Zepbound are identical, an insurer looks at the indication on the prescription before deciding to cover it.

If you have type 2 diabetes, your doctor will usually prescribe Mounjaro, and many diabetes plans cover it well. If your goal is weight loss and you do not have diabetes, the medically appropriate choice is Zepbound, because that is its approved use. Prescribing Mounjaro purely for weight loss is off-label and often flagged by pharmacies and insurers.

This distinction became a real issue during the 2023-2024 shortages, when some people with diabetes struggled to fill Mounjaro because demand for weight loss was high. Keeping the two labels separate helps protect supply for each group. It also affects coupons: Lilly runs different savings programs for each brand, and eligibility depends on your diagnosis and insurance type. For a full walkthrough of lowering your bill, see [how to get GLP-1 cheaper](/blog/how-to-get-glp1-cheaper-savings-cards-telehealth-2026). The takeaway: pick the brand that matches your actual diagnosis, because that is what makes coverage and savings work.

Tirzepatide is currently the most effective weight-loss medication with published data. In the SURMOUNT-1 trial (NEJM, 2022), adults with obesity but without diabetes lost an average of 15% of body weight on the 5 mg dose, 19.5% on 10 mg, and 20.9% on 15 mg over 72 weeks, compared with about 3% on placebo. That means the highest dose helped the average person lose roughly one-fifth of their starting weight.

For people with type 2 diabetes, weight loss tends to be a bit lower. In SURMOUNT-2, adults with obesity and diabetes lost about 12.8% to 14.7% of body weight — still a strong result, since diabetes usually makes weight loss harder.

Beyond the scale, tirzepatide improves blood sugar, blood pressure, and cholesterol markers. The SURMOUNT-OSA trial (2024) showed it significantly reduced sleep apnea severity, which is why Zepbound earned that second approval. If your weight loss eventually slows, that is normal and expected — our guide to the [GLP-1 weight loss plateau](/blog/glp1-weight-loss-plateau-why-stalls-happen-and-how-to-break-them) explains why stalls happen and what actually helps. Results always depend on pairing the medication with enough protein and muscle-preserving movement.

Start with your main health goal, because that points to the right brand. If you have type 2 diabetes, Mounjaro is usually the natural fit and is more likely to be covered under diabetes benefits. If your primary goal is weight loss or you have been diagnosed with obstructive sleep apnea plus obesity, Zepbound is the approved and appropriate choice.

Next, check coverage before you get attached to either name. Call your insurer or use your plan's formulary tool and ask specifically whether tirzepatide is covered, and under which brand. Many plans cover one and not the other. If neither is covered, ask about the Zepbound self-pay vials, which Lilly offers at a lower cash price than the auto-injector pens.

Finally, think about muscle. Because tirzepatide causes fast, significant weight loss, protecting lean muscle matters — especially during midlife. Our guide to [muscle preservation on GLP-1](/blog/muscle-preservation-on-glp1-strength-training-protein-guide) covers the protein and strength-training targets that keep your results healthy. Whichever brand you land on, the medicine inside is the same; your job with your doctor is to match the label to your diagnosis and your budget.

In practice, yes — switching is straightforward because you are staying on the exact same medication and dose. People switch for practical reasons: a change in insurance coverage, a new diagnosis, or a supply issue with one brand. If you move from Mounjaro 7.5 mg to Zepbound, you simply continue at 7.5 mg; there is no need to restart at the lowest dose since your body is already used to tirzepatide.

That said, always make the switch through your prescriber and pharmacist, not on your own. They will write a fresh prescription under the correct brand and confirm the matching dose so there is no gap or doubling up. Never take Mounjaro and Zepbound in the same week — that would be a double dose of tirzepatide and raises your risk of severe nausea, vomiting, and low blood sugar.

If side effects are your reason for wanting a change, switching brands will not help, because the drug is identical. In that case the fix is usually dose timing, diet adjustments, or a different medication entirely. Our overview of [managing GLP-1 nausea](/blog/glp1-nausea-why-it-happens-and-how-to-ease-it) covers the practical steps that make a real difference.